← SynDRA
MK-8033
SynDRA canonical compound SYN0036669 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | MET |
|---|
| Mechanism of action | C-Met inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MET INHIBITOR
- Hepatocyte growth factor receptor inhibitor
- MST1R INHIBITOR
- Macrophage-stimulating protein receptor inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- FECH
- SYK
- AAK1
- NUAK2
- PAK6
- PAK4
- PAK2
- PAICS
- OPA1
- OLA1
- NTRK1
- NDUFA13
- NQO2
- NLK
- NEK9
- NEK7
- NEK3
- NEK2
- PASK
- PDGFRB
- PDXK
- PEBP1
- PRKACB
- PRKACA
- PRKAA1
- PLK4
- PLK1
- PKN3
- PKN2
- PKN1
- PKMYT1
- PIP4K2C
- PIP4K2A
- PIM2
- PIM1
- PHKG2
- PGRMC1
- NEK1
- NAT10
- PRKAG1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- CP2D6
- GAMT
- GNMT
- HNMT
- KSYK
- NNMT
- NSD2
- PNMT
Cross-references
Synonyms
- CPD 11R
- MK8033
- UNII-350H6PBQ5Q
- 3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide
- 350H6PBQ5Q
- CHEMBL2323775
- 1-(3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo(4,5)cyclohepta(1,2-b)pyridin-7-yl)-N-(pyridin-2-ylmethyl)methanesulfonamide
- 1-[2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridin-9-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide
- RefChem:159215
- DTXCID9065493
- C25H21N5O3S
- MFCD18633221
- CS-0560
- SCHEMBL400306
- orb1296122
- SCHEMBL29395425
- VMJFTOSOFDEKTM-UHFFFAOYSA-N
- EX-A2612
- BDBM50427138
- NSC761692
- NSC800797
- AKOS022185323
- NSC-761692
- NSC-800797
- SB16934
- NCGC00378567-01
- NCGC00378567-02
- NCGC00378567-04
- AC-36178
- DA-65511
- HY-13299
- F84513
- BRD-K55512740-001-01-6
Look up MK-8033 in the interactive SynDRA portal →